Genmab — Juli 2018
-
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2018
Company Announcement Net sales of DARZALEX in the second quarter of 2018 totaled USD 511 millionGenmab will receive royalties on worldwide...
GlobeNewswire News Room (www.globenewswire.com)
-
-
MAIA
-
MAIA!
-
i det mindste er vi ret sikre på, at vi sagtens når over 2 milliarder, den tvivl er forsvundet
-
Stigningstakten fra q1 til q2 var 18%
-
holder den resten af året så lander vi på 2255
-
y
-
2 til 2,3
-
@Henrik - USD 2.255.000
-
så jeg først bagefter! -
´meanwile the Danish stock regulators are investigating a certain Mr. @GeorgeBest , senior member of the ProInvestor forum, for trying to influence the Genmab stock price´
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind